Profile
ABVX VRTX ALNY REGN ARGX SGEN
Company Name Abivax S.A. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $6.57B $100.41B $59.77B $58.74B $48.87B $43.15B
Employees 0.07K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Marc M. P. de Garidel Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
ABVX VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 3 1 4 3 3
Quant Rating Sell Neutral Strong Sell Buy Neutral Neutral
Trading
ABVX VRTX ALNY REGN ARGX SGEN
Last Close $86.51 $421.15 $450.68 $563.86 $798.94 $228.74
High 52 $90 $516.74 $482.13 $1016.53 $800 $228.74
Low 52 $5.24 $366.54 $224.58 $482.92 $520.52 $228.74
Price vs. 52 Week High -3.88 % -18.5 % -6.52 % -44.53 % -0.13 % 0 %
Price vs. 52 Week Low 1550.95 % 14.9 % 100.68 % 16.76 % 53.49 % 0 %
Total Return
ABVX VRTX ALNY REGN ARGX SGEN
1 Month Return -3.07 % 6.22 % -6.52 % 1.32 % 4.1 % 0 %
3 Month Return 941.03 % -12.07 % 40.53 % 2.06 % 43.9 % 0 %
6 Month Return 1378.8 % -12.68 % 85.28 % -2.14 % 41.7 % 0 %
9 Month Return 1195.06 % 2.19 % 87.35 % -23.14 % 23.05 % 0 %
YTD Return 1081.83 % 4.58 % 91.53 % -20.84 % 29.91 % 0 %
1 Year Return 834.23 % -10 % 66.36 % -44.29 % 53.49 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVX VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -293.27 % 11.09 % -0.43 % 4.37 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
ABVX VRTX ALNY REGN ARGX SGEN
Asset Growth -37.25 % -0.87 %
Gross Profit Growth 135.94 % 10.25 %
Revenue Growth 133.54 % 11.66 %
Revenue 3 Year 7050.56 % 45.6 %
Revenue 5 Year 104155.36 % 163.93 %
Revenue 10 Year 11236.53 % 1632.15 %
EBIT Growth -29.17 % -93.69 %
Net Income Growth -19.29 % -114.8 %
Net Income 3 Yeari Growth Per Share -1.78 % -122.89 %
Net Income 5 Yeari Growth Per Share -11.16 % -145.38 %
Net Income 10 Yeari Growth Per Share -410.21 % 33.84 %
Operating Income Growth -35.81 % -106.08 %
Operating Cash Flow Growth (CFG) -54.06 % -113.93 %
Operating 3 Year CFG 17.27 % -118.65 %
Operating 5 Year CFG -8.35 % -131.3 %
Operating 10 Year CFG -585.58 % 12.43 %
EPS Growth 18.37 % -114.8 %
EPS Diluted Growth 18.37 % -114.97 %
Book Value Per Share -85.86 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -61.63 % 62.6 %
Share Holder 5 Year Equity Growth Per Share -57.82 % 168.85 %
Share Holder 10 Year Equity Growth Per Share -82.41 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth 75.54 % 116.42 %
Free Cash Flow Growth -54.29 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
ABVX VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 100 % 86.11 % 83.64 % 81.98 % 65.82 % 79.1 %
Return on Assets TTM -163.31 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM 5077.65 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -2731.94 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 98 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 100.12 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -3306.18 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -138.75 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.01 3.59 3.93 3.54 0.9 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.26 0.96
Fixed Asset Turnover TTM 278.97 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 5.03 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -2.16 14.98 -0.12 45.13 5.67 -2.46
Free Cash Flow Per Share TTM -2.17 13.63 -0.4 36.58 5.58 -2.88
Cash Per Share TTM 96.11 % 2486.48 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -2273.9 % 33.68 % -0.63 % 33.37 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.34 % 90.99 % 335.21 % 81.05 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM -138.75 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM -42.36 28.69 -1147.52 15.28 122.57 -81.26
Price To Operating Cash Flows Ratio TTM -34.63 26.14 -3805.41 12.49 140 -93.1
Price Cash Flow Ratio TTM -34.63 26.14 -3805.41 12.49 140 -93.1
Income Statement (TTM)
ABVX VRTX ALNY REGN ARGX SGEN
Revenue $0.01B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0.01B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 100% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.17B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.18B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -2.8 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
ABVX VRTX ALNY REGN ARGX SGEN
Long Term Debt $0.05B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.16B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.04B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.1B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.21B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
ABVX VRTX ALNY REGN ARGX SGEN
Net Income $-0.18B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.15B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 38.3
AARD Aardvark Therapeutics, Inc. Common Stock 16.688
ABCL AbCellera Biologics Inc. 5.99
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.591
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.95
ABPWW 0.0255
ABSI Absci Corporation 4.0216
ABUS Arbutus Biopharma Corporation 4.21
ABVC ABVC BioPharma, Inc. 3.2137
ACAD ACADIA Pharmaceuticals Inc. 21.125
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9666
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.36
ACIU AC Immune SA 3.595
ACLX Arcellx, Inc. 86.99
ETFs With Exposure to ABVX
Ticker ETF Name Weight Percentage Price
DBEZ Xtrackers MSCI Eurozone Hedged Equity ETF 0 54.1751
BOUT Innovator IBD Breakout Opportunities ETF 2.56 39.65
SPEU SPDR Portfolio Europe ETF 0.001349 50.295
MMSC First Trust Multi-Manager Small Cap Opportunities ETF 0.000001 24.056
PINK Simplify Health Care ETF 2.18345 33.08
DBXW.DE Xtrackers MSCI World Swap UCITS ETF 0.249958 118.315
XWEH.F Xtrackers MSCI World Swap UCITS ETF 0.249958 32.014
XWD1.F Xtrackers MSCI World Swap UCITS ETF 0.249958 16.5615
SXRJ.DE iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0665 330.25
XMWD.L Xtrackers MSCI World Swap UCITS ETF 0.249958 137.2
CES1.L iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0539 28635
XWEH.DE Xtrackers MSCI World Swap UCITS ETF 0.249958 46.937
Unlock